12cm operates echoss, a cloud-based platform that connects offline services to mobile applications, facilitating real-time interactions between businesses and consumers. This technology addresses the challenge of bridging the gap between physical and digital customer engagement, enhancing user experience and operational efficiency.

1STBIO develops novel therapeutics targeting neurodegenerative diseases, immuno-oncology, and rare diseases through a genomic-based target discovery platform. The company addresses significant unmet medical needs by transforming breakthrough scientific discoveries into effective medicines for patients.

The startup offers a semiconductor design platform that utilizes machine learning for automated modeling, enabling self-learning from collected data. This technology reduces development time and minimizes design errors, enhancing the efficiency of semiconductor design processes.

The startup develops human hyaluronidase technology to enhance the delivery of therapeutics for complex health conditions. This technology improves the efficacy of treatments by facilitating the dispersion of medications in tissues, thereby aiding in patient recovery.

bitsensing develops automotive-grade radar technology for smart city applications, enhancing urban traffic management and public safety through precise monitoring and data analysis. Their solutions improve the reliability of traffic flow and safety measures, addressing the challenges of congestion and urban safety in connected environments.

The startup offers a mobile insurance application that enables users to monitor their insurance policies, compare various insurance products, and receive personalized recommendations based on their profiles. This platform provides a centralized solution for individuals seeking to navigate the complexities of insurance options and select suitable planners for their needs.

Ceres FD is a biopharmaceutical company that manufactures immunosuppressants and antibiotic drug substances, including Tacrolimus, Teicoplanin, and Vancomycin, using advanced synthesis techniques. The company provides essential drug substances that address the critical need for effective immunosuppression and infection control in patients undergoing organ transplants and those with severe infections.

The startup operates an online platform that enables patients and caregivers to compare medical services and fees from healthcare professionals worldwide. This platform connects hospitals and clinics with a global audience, facilitating informed healthcare decisions and improving access to quality medical advice.

The startup offers a cooking application that provides users with curated recipes, cooking tips, and table styling videos, along with lifestyle product recommendations and food boxes containing all necessary ingredients. This platform enhances the cooking experience by catering to diverse culinary needs and simplifying meal preparation for various occasions.

Deaver is a delivery management app that provides real-time tracking and transparent pricing for users, enabling them to schedule pickups and deliveries efficiently. The platform addresses the need for quick and reliable delivery services, particularly for urgent shipments and corporate logistics, by offering features like expedited delivery options and dedicated customer support.

Eutilex develops immunotherapy technologies, including anti-tumor T cell therapy and antibody therapeutics, to treat incurable diseases. Their focus on T cell and CAR-T therapies aims to provide effective treatment options for patients with resistant and untreatable conditions.

The startup offers a peer-to-peer lending platform that connects small and medium enterprises directly with investors, utilizing advanced algorithms to streamline the funding process. This approach reduces the costs and complexities associated with traditional financing, enabling faster access to affordable capital.

GenKOre specializes in gene editing technologies, particularly CRISPR, to develop targeted gene therapies for genetic disorders such as Huntington's disease. The company addresses the limitations of traditional treatments by utilizing patient-specific cells to minimize immune rejection and reduce treatment costs.

Humanscape operates a blockchain-based health data platform specifically designed for patients with rare diseases, enabling secure and transparent sharing of health information. This platform addresses the challenge of fragmented patient data, facilitating better access to treatment options and improving outcomes for individuals with rare conditions.

The startup develops treatments for metabolic diseases by utilizing technology to reduce advanced glycation endproducts (AGEs), which are harmful sugar toxins. This approach enables the creation of customized medical foods tailored to individual patient needs through consultations at hospitals, clinics, and pharmacies.

Monolith develops smart parks that integrate advanced technology with play spaces for children, enhancing interactive and educational experiences. The company addresses the lack of engaging and safe recreational environments by creating spaces that promote physical activity and social interaction through innovative design and technology.

The startup develops anti-cancer combination therapies and neutropenia medications to mitigate the side effects of cancer treatments and enhance the efficacy of existing drugs. By targeting the adverse effects associated with cancer therapies, the company aims to improve patient outcomes and quality of life during treatment.

Novelpia is a unified web‑novel and webtoon platform that aggregates a large catalog of serialized stories for Korean readers. It rewards user engagement with virtual currencies earned through daily quests and events, which can be spent on premium chapters, rentals, or purchases, while a Plus Membership offers ad‑free, unlimited reading and bonus rewards.

Nurihaus provides a cross-border e-commerce platform that connects K-beauty brands with global consumers through influencer-driven marketing strategies. The company addresses the challenges of international market entry by offering tailored distribution solutions and localized marketing insights for beauty brands seeking to expand their reach.

The startup develops machine intelligence software that digitizes industrial data into actionable insights through predictive analytics and optimized hardware for real-time processing. This technology enables companies to accurately assess the risk of equipment failure and estimate the remaining life of critical assets, facilitating timely and informed business decisions.

PineTree Therapeutics is developing the AbReptor and TAER-TAB platforms, which utilize bispecific and multi-specific antibodies to target and degrade membrane-bound and extracellular proteins in cancer cells. These therapies aim to address the unmet medical needs in oncology by effectively targeting difficult-to-reach receptors across various cancer types.

The startup develops therapeutic drugs that leverage the ubiquitin-proteasome system to regulate protein levels in the body. This approach targets diseases such as cancer by utilizing natural biological processes for protein degradation.

The startup specializes in upcycling automotive batteries through disassembly, repair, and reassembly processes to restore their original performance and extend their lifecycle. This approach reduces battery replacement costs and enables the reuse of batteries for various applications, including uninterruptible power supplies and mobility solutions.

The startup manufactures specialized materials such as packaging for secondary batteries, functional coatings for electronic components, and recycled plastics, enabling industries to enhance material processing and establish efficient recycling systems. By providing these tailored solutions, the company addresses the need for sustainable resource management in manufacturing and electric vehicle production.